NCT04692155 2023-09-28CHOP U2University of Alabama at BirminghamPhase 1/2 Terminated1 enrolled 5 charts
NCT04635683 2022-09-30Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell LymphomaOhio State University Comprehensive Cancer CenterPhase 1 Withdrawn